eClinical Software: June 2009
Applied Clinical Trials
The latest eclinical software in the clinical trials industry.
Content Management Connectivity
Standalone software supports popular content management systems
Octagon Research Solutions (Wayne, PA) announced ViewPoint Connect Module. The standalone software supports connectivity to content management systems including EMC's Documentum 6; OpenText Livelink 9.7.1; Oracle Content DB 10.2; and Microsoft SharePoint 3.0. ViewPoint Connector is also available as a module to the company's flagship process management solution, ViewPoint, which accesses content management systems for managing and controlling content-driven enterprise processes such as global regulatory submissions.
ViewPoint Connector is a layer that sits over proprietary API toolkits to provide a single unified access point to pieces of content and metadata across various repositories.
Octagon Research Solutions, (610) 535-6500, www.octagonresearch.com
Clinical Trial Management System for Sites
Software adds features to increase research site productivity
Bio-Optronics (Rochester, NY) has enhanced its Clinical Conductor Site Clinical Trial Management System (CTMS) to include increased patient database function, improved QuickBooks integration, and updated financial management and reporting. Also updated is its patient Virtual Recruitment and Business Development modules.
The Web-based Virtual Recruiter enables sites to use the Web to prequalify potential study participants. Screening questions are highly configurable to the desired level of detail. The Business Development solution provides full tracking and management of trial opportunities and actions. Both modules integrate with Clinical Conductor. The company is also cross-marketing and integrating its CTMS with flexcipio's eClinical Electronic Data Capture solution.
Bio-Optronics, (585) 272-1960, www.bio-optronics.com
Report Generation Function Expanded
EDC and CTMS now offers more powerful data mining
Nextrials (San Ramon, CA) announced its Prism data capture and clinical trial management platform has increased its report generation function to deliver more powerful data mining capabilities to customers. With the improved ad hoc reporting feature, users can now collect, summarize, and export data from tables within a single study or across multiple studies.
Its user-friendly graphical interface also includes advanced interactive data view formats, such as heat maps, in addition to bar graphs, pie charts, and other standard visual templates. It also includes preview panes to help users visualize reports in progress; enhanced export capabilities; and concomitant medication and adverse event coding data integration.
Nextrials, (925) 355-3000, www.nextrials.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
